Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients

ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China

(2013) Liming Sheng et al.   INTERNATIONAL JOURNAL OF CANCER

Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen

(2012) Jun Zhao et al.   BMC CANCER

High D-dimer levels are associated with poor prognosis in cancer patients

(2012) C. Ay et al.   HAEMATOLOGICA

Clinical and prognostic significance of coagulation assays in lung cancer

(2012) Faruk Tas et al.   RESPIRATORY MEDICINE

Increases in Quantitative D-Dimer Levels Correlate With Progressive Disease Better Than Circulating Tumor Cell Counts in Patients With Refractory Prostate Cancer

(2010) Joseph D. Khoury et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma

(2009) Ilya V Tsimafeyeu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Small Cell Lung Cancer

(2009) Taimur Sher et al.   MAYO CLINIC PROCEEDINGS

Survival and prognostic factors in small cell lung cancer

(2009) Jian Li et al.   MEDICAL ONCOLOGY

An overview of coagulation disorders in cancer patients

(2009) Slavica Kvolik et al.   SURGICAL ONCOLOGY-OXFORD

Plasma Levels of Prothrombin Fragment F1+2, D-dimer and Prothrombin Time Correlate with Clinical Stage and Lymph Node Metastasis in Operable Gastric Cancer Patients

(2008) H.-C. Kwon et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY